CDEK
← All drugs Report issue

cd123 car-t cells

Cell therapyexperimental

Clinical trial activity

17 trials · 19 clinical orgs · 0 marketing orgs

Phase 1
16
Phase 2
7
Phase 3
0
Phase 4
0

Earliest trial started Oct 1, 2016 (NCT02937103)

Timeline

2010s

  1. Jan 1, 2016

    Earliest Phase 1 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • anti-cd123-car t cells

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07201727Early Phase 1 (Phase 1)Sep 30, 2025China Academy of Chinese Medical Sciences
NCT06917105Phase 1/Phase 2 (Phase 2)Apr 1, 2025Government of China, Huazhong University of Science and Technology
NCT06768476Phase 1Feb 28, 2025Novartis, University of Pennsylvania
NCT06765876Early Phase 1 (Phase 1)Oct 23, 2024Institute of Hematology and Blood Transfusion, Czech Republic
NCT06420063Phase 1/Phase 2 (Phase 2)Jul 10, 2024Essen Biotech
NCT04678336Phase 1Jan 31, 2021University of Pennsylvania
NCT04318678Phase 1Apr 30, 2020St. Jude Children's Hospital
NCT04272125Phase 1/Phase 2 (Phase 2)Dec 1, 2019Chongqing Medical University, Chongqing Precision Biotech Co., Ltd
NCT04265963Phase 1/Phase 2 (Phase 2)Sep 1, 2019Chongqing Medical University, Chongqing Precision Biotech Co., Ltd, People's Liberation Army of China
NCT04010877Phase 1/Phase 2 (Phase 2)Aug 1, 2019Shenzhen Geno-Immune Medical Institute
NCT03796390Phase 1Dec 26, 2018Hebei Senlang Biotechnology Inc., Ltd., Ludaopei Hospital
NCT03766126Phase 1Dec 6, 2018University of Pennsylvania
NCT03672851Phase 1Sep 17, 2018GenScript, Jiao Tong University
NCT03585517Phase 1Jul 21, 2018Beijing Immunochina Medical Science & Technology Co., Ltd.
NCT03473457N/AApr 1, 2018Southern Medical University, Sun Yat-Sen University
NCT03556982Phase 1/Phase 2 (Phase 2)Mar 1, 2018People's Liberation Army of China
NCT02937103Phase 1/Phase 2 (Phase 2)Oct 1, 2016People's Liberation Army of China
Showing 17 of 17 trials
Page 1 / 1

Organizations

Research & Development (19)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
People's Liberation Army of ChinaGovernment3212016
University of PennsylvaniaAcademic/Hospital3312018
Chongqing Medical UniversityAcademic/Hospital2012019
Chongqing Precision Biotech Co., LtdFor profit2212019
Beijing Immunochina Medical Science & Technology Co., Ltd.For profit1112018
China Academy of Chinese Medical SciencesAcademic/Hospital1112025
Essen BiotechFor profit1112024
GenScriptFor profit1012018
Government of ChinaGovernment1012025
Hebei Senlang Biotechnology Inc., Ltd.For profit1112018
Huazhong University of Science and TechnologyAcademic/Hospital1112025
Institute of Hematology and Blood Transfusion, Czech RepublicAcademic/Hospital1112024
Jiao Tong UniversityAcademic/Hospital1112018
Ludaopei HospitalAcademic/Hospital1012018
NovartisFor profit1012025
Shenzhen Geno-Immune Medical InstituteAcademic/Hospital1112019
Southern Medical UniversityAcademic/Hospital1112018
St. Jude Children's HospitalAcademic/Hospital1112020
Sun Yat-Sen UniversityAcademic/Hospital1012018
19 organizations
Page 1 / 1